Catalyst Wire Dossier Catalyst Wire Dossier

Lutetium-177 DOTATATE (Lutathera)

lutetium-177 dotatate · Novartis
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Lutetium-177 DOTATATE (Lutathera), covering 2025-03-11 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Italian Multicenter Experience With Radioreceptor-assisted Therapy (PRRT)

See pricing